Screener
Agilon Health AGL Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Agilon Health’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053355
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net income (loss) | $66,872 | $(92,258) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depreciation and amortization | 13,651 | 14,195 |
| Stock-based compensation expense | 30,087 | 32,101 |
| Loss (income) from equity method investments | (4,137) | (18,084) |
| Adjustments on sale of assets, net | (19,000) | (14,000) |
| Other, net | 1,377 | (3,107) |
| Changes in operating assets and liabilities | (122,419) | 14,081 |
Item 1. Financial Statements
FAQ
- What is Agilon Health's stock-based comp?
- Agilon Health (AGL) reported stock-based comp of $23.83M in Q2 2026.
- How has Agilon Health's stock-based comp changed year-over-year?
- Agilon Health's stock-based comp increased by 54.9% year-over-year, from $15.38M to $23.83M.
- What is the long-term trend for Agilon Health's stock-based comp?
- Over 4 years (2021 to 2025), Agilon Health's stock-based comp has grown at a -36.0% compound annual growth rate (CAGR), from $292.39M to $49.12M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Agilon Health's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude